Dermatology solutions provider Connect Medical Value (CMV) has secured “millions of US dollars” in its Series A round of financing led by Sequoia Capital China.
Lifescience-focused Hangzhou Wanlun Shangde Investment participated in the round as a new investor, per a company statement.
Early-stage healthcare investment firm Marathon Venture Partners made a follow-on investment in the round.
Proceeds from the latest round will be used to level up its digital healthcare management platform, and to enhance its talent pool.
Connect Medical Value, also known as Yongliu Technology, uses AI to develop skin disease-based digital healthcare management platforms and solutions.
CHINA DEAL MONITOR
DealStreetAsia has also put together a table listing out all prominent venture capital transactions in the Greater China region on April 07, 2021.
